Cronos Group Inc. Common Share (CRON) Stock Price

CRONStock

$3.51+31.30%52W

Market Cap$1.29B

P/E24.31x

PEG Ratio—

Div yield—

Beta1.21

CRON Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)18.62%

Price vs S&P 500 (4W)13.70%

VGM Score58.12

P/E Ratio (Annual)24.31x

P/CF (Annual)45.26x

Book Value / Share (Quarterly)$2.85

P/TBV (Annual)0.91x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)16.84%

Cash Flow / Share (Quarterly)$0.07

Price vs S&P 500 (YTD)20.54%

Gross Margin (TTM)42.74%

Net Profit Margin (TTM)-1.14%

EPS (TTM)$-0.00

10-Day Avg Trading Volume0.19M

EPS Excl Extra (TTM)$-0.00

Revenue Growth (5Y)25.70%

EPS (Annual)$-0.02

ROI (Annual)-0.86%

Gross Margin (Annual)42.81%

Net Profit Margin (5Y Avg)-154.41%

Cash / Share (Quarterly)$2.18

P/E Basic Excl Extra (TTM)27.67x

Revenue Growth QoQ (YoY)40.13%

EPS Growth (5Y)-49.98%

P/E Normalized (Annual)24.31x

ROA (Last FY)-0.79%

Revenue Growth TTM (YoY)28.05%

EBITD / Share (TTM)$-0.03

ROE (5Y Avg)-9.62%

Operating Margin (TTM)-9.50%

Cash Flow / Share (Annual)$-0.00

P/B Ratio1.09x

P/B Ratio (Quarterly)0.89x

Net Income / Employee (Annual)$-15,100

EV / Revenue (TTM)2.19x

Net Interest Coverage (TTM)-44.46x

ROA (TTM)-0.15%

EPS Growth QoQ (YoY)127.85%

EV / EBITDA (TTM)1125.57x

EPS Incl Extra (Annual)$-0.02

Current Ratio (Annual)19.59x

Quick Ratio (Quarterly)20.61x

3-Month Avg Trading Volume0.18M

52-Week Price Return31.30%

EV / Free Cash Flow (Annual)37.72x

P/E Incl Extra (TTM)27.67x

Revenue / Employee (TTM)$254,800

Tangible BV / Share (Quarterly)$2.83

P/S Ratio (Annual)7.99x

Asset Turnover (Annual)0.12x

52-Week High$4.78

Operating Margin (5Y Avg)-232.78%

EPS Excl Extra (Annual)$-0.02

CapEx CAGR (5Y)-5.94%

Tangible BV CAGR (5Y)-7.95%

26-Week Price Return29.86%

Quick Ratio (Annual)18.45x

13-Week Price Return25.73%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)21.87x

Enterprise Value$348.93M

Revenue / Share Growth (5Y)23.53%

Asset Turnover (TTM)0.14x

Book Value / Share Growth (5Y)-9.61%

Revenue / Employee (Annual)$234,200

Inventory Turnover (Annual)2.10x

Pretax Margin (Annual)-11.68%

Cash / Share (Annual)$2.18

3-Month Return Std Dev40.17%

Gross Margin (5Y Avg)14.22%

Net Income / Employee (TTM)$-2,900

ROE (Last FY)-0.86%

Net Interest Coverage (Annual)-0.43x

EPS Basic Excl Extra (Annual)$-0.02

P/FCF (TTM)43.03x

Receivables Turnover (TTM)6.17x

EV / Free Cash Flow (TTM)13.32x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.00

Receivables Turnover (Annual)5.92x

ROI (TTM)-0.17%

P/S Ratio (TTM)7.34x

Pretax Margin (5Y Avg)-146.04%

Revenue / Share (Annual)$0.38

Tangible BV / Share (Annual)$2.84

Forward P/E28.91x

Price vs S&P 500 (52W)12.99%

P/E Ratio (TTM)27.67x

Year-to-Date Return31.67%

5-Day Price Return6.52%

EPS Normalized (Annual)$-0.02

ROA (5Y Avg)-9.20%

Net Profit Margin (Annual)-6.44%

Month-to-Date Return20.00%

Cash Flow / Share (TTM)$-0.34

EBITD / Share (Annual)$-0.04

Operating Margin (Annual)-11.87%

LT Debt / Equity (Annual)0.06x

P/CF (TTM)30.13x

ROI (5Y Avg)-9.62%

P/E Excl Extra (TTM)27.67x

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.00

P/TBV (Quarterly)0.90x

P/B Ratio (Annual)0.90x

Inventory Turnover (TTM)2.19x

Pretax Margin (TTM)-3.92%

Book Value / Share (Annual)$2.87

Price vs S&P 500 (13W)22.94%

Net Margin Growth (5Y)-62.81%

Beta1.21x

P/FCF (Annual)205.80x

Revenue / Share (TTM)$0.42

ROE (TTM)-0.17%

52-Week Low$3.23

vGradeC

gGradeB

mGradeB

vgmGradeC

CRON Earnings Surprise History

Q2 25-0.14est. -0.03

Q3 250.10est. 0.00

Q4 250.00est. 0.02

Q1 260.05est. 0.01

Q2 260.13est. 0.01

CRON Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.11

Industry Peers — Pharmaceutical Preparations(21)

Symbol	Value Score	Growth Score	Momentum Score	Price
CRONCronos Group Inc. Common Share	C	B	B	$3.51
DFTXDefinium Therapeutics, Inc. Common Shares	—	—	A	$44.81
RGCRegencell Bioscience Holdings Limited Ordinary Shares	—	—	F	$5.54
TRLVTrulieve Cannabis Corp.	B	C	A	$11.32
GLASGlass House Brands Inc.	C	C	C	$10.13
TLRYTilray Brands, Inc. Common Stock	B	B	D	$4.88
CGCCanopy Growth Corporation Common Shares	B	C	C	$1.07
SNDLSundial Growers Inc. Common Shares	A	C	C	$1.37
NAGENiagen Bioscience, Inc. Common Stock	C	C	D	$3.27
USNAUSANA Health Sciences Inc	B	D	D	$13.78
ACBAurora Cannabis Inc. Common Shares	B	D	C	$4.01
MDWDMediWound Ltd.	C	F	D	$12.97
FTLFFitLife Brands, Inc. Common Stock	B	C	D	$10.05
BTMDBiote Corp. Class A Common Stock	A	D	D	$1.58
NAIINatural Alternatives International Inc.	A	C	D	$2.17
MTEXMannatech Inc.	B	D	C	$6.45
BONBon Natural Life Limited Class A Ordinary Shares	B	D	D	$1.14
AKANAkanda Corp. Common Shares	C	F	F	$4.95
IMCCIM Cannabis Corp. Common Shares	A	B	F	$0.11
SNYRSynergy CHC Corp. Common Stock	A	C	F	$0.10
MEHAFunctional Brands, Inc. Common Stock	A	C	F	$0.00
TRUUVanEck Utilities TruSector ETF	—	—	D	$23.68

About Cronos Group Inc. Common Share

Cronos Group Inc is a cannabis company with operations in Canada, Israel, and other markets, generating the majority of its revenue from Canada. The company's brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. Cronos focuses on cannabis research, technology, and product development to drive competitive differentiation.